Which has higher valuation and earnings, ECOR or LFWD?

electroCore has higher revenue and earnings than Lifeward. electroCore is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio electroCore $32.03M 2.83 -$13.97M -$1.66 N/A Lifeward $22.03M 0.91 -$19.91M -$16.82 N/A

Is ECOR or LFWD more profitable?

electroCore has a net margin of -39.96% compared to Lifeward's net margin of -141.28%. Lifeward's return on equity of -235.86% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -39.96% -1,956.38% -81.35% Lifeward -141.28% -235.86% -81.72%

Does the media prefer ECOR or LFWD?

In the previous week, Lifeward had 1 more articles in the media than electroCore. MarketBeat recorded 5 mentions for Lifeward and 4 mentions for electroCore. Lifeward's average media sentiment score of 0.78 beat electroCore's score of 0.47 indicating that Lifeward is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lifeward 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, CVRX or LFWD?

Lifeward has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 1.41 -$53.31M -$1.98 N/A Lifeward $22.03M 0.91 -$19.91M -$16.82 N/A

Is CVRX or LFWD more profitable?

CVRx has a net margin of -84.93% compared to Lifeward's net margin of -141.28%. CVRx's return on equity of -152.35% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Lifeward -141.28% -235.86% -81.72%

Does the media refer more to CVRX or LFWD?

In the previous week, Lifeward had 1 more articles in the media than CVRx. MarketBeat recorded 5 mentions for Lifeward and 4 mentions for CVRx. Lifeward's average media sentiment score of 0.78 beat CVRx's score of 0.47 indicating that Lifeward is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lifeward 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is LFWD or NRXS more profitable?

Lifeward has a net margin of -141.28% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -141.28% -235.86% -81.72% NeurAxis -492.76% N/A -641.25%

Does the media favor LFWD or NRXS?

In the previous week, Lifeward had 4 more articles in the media than NeurAxis. MarketBeat recorded 5 mentions for Lifeward and 1 mentions for NeurAxis. NeurAxis' average media sentiment score of 1.24 beat Lifeward's score of 0.78 indicating that NeurAxis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifeward 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeurAxis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate LFWD or DXR?

Lifeward currently has a consensus price target of $10.00, suggesting a potential upside of 41.44%. Given Lifeward's higher possible upside, equities analysts clearly believe Lifeward is more favorable than Daxor. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifeward 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable earnings & valuation, LFWD or DXR?

Daxor has lower revenue, but higher earnings than Lifeward. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lifeward $22.03M 0.91 -$19.91M -$16.82 N/A Daxor N/A N/A N/A N/A N/A

Is LFWD or DXR more profitable?

Daxor has a net margin of 0.00% compared to Lifeward's net margin of -141.28%. Daxor's return on equity of 0.00% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -141.28% -235.86% -81.72% Daxor N/A N/A N/A

Does the media prefer LFWD or DXR?

In the previous week, Lifeward had 1 more articles in the media than Daxor. MarketBeat recorded 5 mentions for Lifeward and 4 mentions for Daxor. Daxor's average media sentiment score of 0.97 beat Lifeward's score of 0.78 indicating that Daxor is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifeward 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Daxor 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is OM or LFWD more profitable?

Outset Medical has a net margin of -63.06% compared to Lifeward's net margin of -141.28%. Outset Medical's return on equity of -61.67% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Outset Medical -63.06% -61.67% -28.25% Lifeward -141.28% -235.86% -81.72%

Lifeward (LFWD) Competitors

$7.07 -0.04 (-0.56%)

Closing price 03:59 PM Eastern

Extended Trading

$7.14 +0.07 (+1.06%)

As of 04:10 PM Eastern

Compare

LFWD vs. ECOR, CVRX, NRXS, DXR, and OM

Should you buy Lifeward stock or one of its competitors? Lifeward's main competitors and comparable companies include electroCore (ECOR), CVRx (CVRX), NeurAxis (NRXS), Daxor (DXR), and Outset Medical (OM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Lifeward compare to electroCore?

electroCore (NASDAQ:ECOR) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

electroCore has a net margin of -39.96% compared to Lifeward's net margin of -141.28%. Lifeward's return on equity of -235.86% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
Lifeward	-141.28%	-235.86%	-81.72%

26.7% of electroCore shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 7.8% of electroCore shares are owned by company insiders. Comparatively, 1.5% of Lifeward shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

electroCore has higher revenue and earnings than Lifeward. electroCore is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	2.83	-$13.97M	-$1.66	N/A
Lifeward	$22.03M	0.91	-$19.91M	-$16.82	N/A

In the previous week, Lifeward had 1 more articles in the media than electroCore. MarketBeat recorded 5 mentions for Lifeward and 4 mentions for electroCore. Lifeward's average media sentiment score of 0.78 beat electroCore's score of 0.47 indicating that Lifeward is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lifeward	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

electroCore presently has a consensus target price of $18.00, indicating a potential upside of 79.10%. Lifeward has a consensus target price of $10.00, indicating a potential upside of 41.44%. Given electroCore's higher possible upside, analysts clearly believe electroCore is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

electroCore has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Lifeward has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market.

Summary

electroCore beats Lifeward on 9 of the 16 factors compared between the two stocks.

How does Lifeward compare to CVRx?

CVRx (NASDAQ:CVRX) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Lifeward had 1 more articles in the media than CVRx. MarketBeat recorded 5 mentions for Lifeward and 4 mentions for CVRx. Lifeward's average media sentiment score of 0.78 beat CVRx's score of 0.47 indicating that Lifeward is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lifeward	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lifeward has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.41	-$53.31M	-$1.98	N/A
Lifeward	$22.03M	0.91	-$19.91M	-$16.82	N/A

CVRx presently has a consensus price target of $5.30, indicating a potential upside of 76.67%. Lifeward has a consensus price target of $10.00, indicating a potential upside of 41.44%. Given CVRx's higher possible upside, equities analysts clearly believe CVRx is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

CVRx has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Lifeward has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market.

CVRx has a net margin of -84.93% compared to Lifeward's net margin of -141.28%. CVRx's return on equity of -152.35% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Lifeward	-141.28%	-235.86%	-81.72%

75.3% of CVRx shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 16.6% of CVRx shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

CVRx beats Lifeward on 10 of the 15 factors compared between the two stocks.

How does Lifeward compare to NeurAxis?

Lifeward (NASDAQ:LFWD) and NeurAxis (NASDAQ:NRXS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

In the previous week, Lifeward had 4 more articles in the media than NeurAxis. MarketBeat recorded 5 mentions for Lifeward and 1 mentions for NeurAxis. NeurAxis' average media sentiment score of 1.24 beat Lifeward's score of 0.78 indicating that NeurAxis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lifeward	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeurAxis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeurAxis has lower revenue, but higher earnings than Lifeward. NeurAxis is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.91	-$19.91M	-$16.82	N/A
NeurAxis	$5.32M	13.46	-$14.63M	-$0.78	N/A

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 21.1% of NeurAxis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Lifeward presently has a consensus price target of $10.00, suggesting a potential upside of 41.44%. NeurAxis has a consensus price target of $13.00, suggesting a potential upside of 128.07%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts clearly believe NeurAxis is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Lifeward has a beta of 0.39, indicating that its share price is 61% less volatile than the broader market. Comparatively, NeurAxis has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

Lifeward has a net margin of -141.28% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-141.28%	-235.86%	-81.72%
NeurAxis	-492.76%	N/A	-641.25%

Summary

NeurAxis beats Lifeward on 9 of the 16 factors compared between the two stocks.

How does Lifeward compare to Daxor?

Lifeward (NASDAQ:LFWD) and Daxor (NASDAQ:DXR) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

Daxor has lower revenue, but higher earnings than Lifeward.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.91	-$19.91M	-$16.82	N/A
Daxor	N/A	N/A	N/A	N/A	N/A

Daxor has a net margin of 0.00% compared to Lifeward's net margin of -141.28%. Daxor's return on equity of 0.00% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-141.28%	-235.86%	-81.72%
Daxor	N/A	N/A	N/A

Lifeward has a beta of 0.39, meaning that its share price is 61% less volatile than the broader market. Comparatively, Daxor has a beta of 0.26, meaning that its share price is 74% less volatile than the broader market.

26.8% of Lifeward shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 1.5% of Lifeward shares are held by insiders. Comparatively, 51.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Lifeward currently has a consensus price target of $10.00, suggesting a potential upside of 41.44%. Given Lifeward's higher possible upside, equities analysts clearly believe Lifeward is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Lifeward had 1 more articles in the media than Daxor. MarketBeat recorded 5 mentions for Lifeward and 4 mentions for Daxor. Daxor's average media sentiment score of 0.97 beat Lifeward's score of 0.78 indicating that Daxor is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lifeward	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Daxor	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Lifeward and Daxor tied by winning 6 of the 12 factors compared between the two stocks.

How does Lifeward compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Outset Medical has a net margin of -63.06% compared to Lifeward's net margin of -141.28%. Outset Medical's return on equity of -61.67% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
Lifeward	-141.28%	-235.86%	-81.72%

Outset Medical currently has a consensus price target of $10.00, suggesting a potential upside of 218.47%. Lifeward has a consensus price target of $10.00, suggesting a potential upside of 41.44%. Given Outset Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Outset Medical is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

26.8% of Lifeward shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Comparatively, 1.5% of Lifeward shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Lifeward had 4 more articles in the media than Outset Medical. MarketBeat recorded 5 mentions for Lifeward and 1 mentions for Outset Medical. Outset Medical's average media sentiment score of 1.89 beat Lifeward's score of 0.78 indicating that Outset Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Outset Medical	Very Positive
Lifeward	Positive

Lifeward has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.49	-$81.65M	-$4.09	N/A
Lifeward	$22.03M	0.91	-$19.91M	-$16.82	N/A

Outset Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.39, suggesting that its stock price is 61% less volatile than the broader market.

Summary

Outset Medical beats Lifeward on 11 of the 16 factors compared between the two stocks.

Get Lifeward News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFWD vs. The Competition

Export

Metric	Lifeward	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$20.14M	$5.55B	$7.21B	$15.01B
Dividend Yield	N/A	1.79%	2.57%	12.21%
P/E Ratio	-0.42	25.06	272.84	25.31
Price / Sales	0.91	72.21	651.75	87.56
Price / Cash	N/A	32.78	77.71	51.48
Price / Book	1.28	5.99	10.37	6.18
Net Income	-$19.91M	$150.13M	$3.49B	$357.96M
7 Day Performance	-5.01%	-2.23%	-2.20%	-1.61%
1 Month Performance	-5.10%	-3.84%	-0.38%	-3.62%
1 Year Performance	4.80%	10.26%	19.16%	5.95%

Lifeward Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFWD Lifeward	2.5882 of 5 stars	$7.07 -0.6%	$10.00 +41.4%	+1.3%	$20.14M	$22.03M	N/A	60	News Coverage Gap Up
ECOR electroCore	2.5349 of 5 stars	$8.99 -1.0%	$18.00 +100.2%	+105.9%	$81.09M	$32.03M	N/A	50
CVRX CVRx	4.0047 of 5 stars	$2.83 -3.6%	$5.30 +87.6%	-61.9%	$75.26M	$61.19M	N/A	160	Analyst Upgrade
NRXS NeurAxis	1.8553 of 5 stars	$5.73 -3.0%	$13.00 +126.9%	+137.1%	$71.96M	$5.32M	N/A	19	News Coverage
DXR Daxor	1.3272 of 5 stars	$10.76 +2.9%	N/A	-3.3%	$62.82M	$8.15M	N/A	37	News Coverage Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFWD) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifeward (LFWD) Competitors

LFWD vs. ECOR, CVRX, NRXS, DXR, and OM

How does Lifeward compare to electroCore?

Summary

How does Lifeward compare to CVRx?

Summary

How does Lifeward compare to NeurAxis?

Summary

How does Lifeward compare to Daxor?

Summary

How does Lifeward compare to Outset Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFWD vs. The Competition

Lifeward Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifeward (LFWD) Competitors

LFWD vs. ECOR, CVRX, NRXS, DXR, and OM

How does Lifeward compare to electroCore?

Is ECOR or LFWD more profitable?

Do insiders & institutionals hold more shares of ECOR or LFWD?

Which has higher valuation and earnings, ECOR or LFWD?

Does the media prefer ECOR or LFWD?

Do analysts rate ECOR or LFWD?

Which has more risk and volatility, ECOR or LFWD?

Summary

How does Lifeward compare to CVRx?

Does the media refer more to CVRX or LFWD?

Which has better valuation and earnings, CVRX or LFWD?

Do analysts prefer CVRX or LFWD?

Which has more volatility and risk, CVRX or LFWD?

Is CVRX or LFWD more profitable?

Do insiders & institutionals believe in CVRX or LFWD?

Summary

How does Lifeward compare to NeurAxis?

Does the media favor LFWD or NRXS?

Which has better valuation & earnings, LFWD or NRXS?

Do insiders and institutionals have more ownership in LFWD or NRXS?

Do analysts recommend LFWD or NRXS?

Which has more volatility and risk, LFWD or NRXS?

Is LFWD or NRXS more profitable?

Summary

How does Lifeward compare to Daxor?

Which has preferable earnings & valuation, LFWD or DXR?

Is LFWD or DXR more profitable?

Which has more risk and volatility, LFWD or DXR?

Do insiders & institutionals hold more shares of LFWD or DXR?

Do analysts rate LFWD or DXR?

Does the media prefer LFWD or DXR?

Summary

How does Lifeward compare to Outset Medical?

Is OM or LFWD more profitable?

Do analysts rate OM or LFWD?

Do institutionals and insiders hold more shares of OM or LFWD?

Does the media favor OM or LFWD?

Which has higher earnings & valuation, OM or LFWD?

Which has more volatility & risk, OM or LFWD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFWD vs. The Competition

Lifeward Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools